Century Therapeutics, Inc.

IPSCNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$109.2M

▲ 1556.8% YoY

Net Income

-$9.6M

▲ 92.4% YoY

EPS

$-0.14

▲ 91.3% YoY

Cash

$61.9M

▲ 5.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.